Advertisement
Screener

FATE THERAPEUTICS INC (FATE) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

FATE THERAPEUTICS INC Capital Expenditures

FATE THERAPEUTICS INC (FATE) reported Capital Expenditures of $319.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13

  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $80.00K, a 94.13% decline year-over-year.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $239.00K, a 80.02% decline year-over-year.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.19M, a 1116.33% increase year-over-year.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.20M, a 345.05% increase year-over-year.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for fiscal 2025 was $5.95M, a 715.48% increase from fiscal 2024.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for fiscal 2024 was $730.00K, a 88.14% decline from fiscal 2023.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for fiscal 2023 was $6.15M, a 82.70% decline from fiscal 2022.
  • FATE THERAPEUTICS INC payments to acquire property, plant, and equipment for fiscal 2022 was $35.57M, a 29.86% decline from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 77 monthPayments to Acquire Property, Plant, and Equipment 80 monthPayments to Acquire Property, Plant, and Equipment 83 month
2026-06-30$80.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$319.00K
10-Q · filed 2026-08-13
$1.51M
derived: sum of 3 quarters · filed 2026-08-13
$3.71M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$239.00K
10-Q · filed 2026-05-13
$1.43M
derived: sum of 2 quarters · filed 2026-05-13
$3.63M
derived: sum of 3 quarters · filed 2026-05-13
$5.00M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.40M
derived: sum of 2 quarters · filed 2026-02-26
$4.76M
derived: sum of 3 quarters · filed 2026-08-13
$5.95M
10-K · filed 2026-02-26
2025-09-30$2.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$3.56M
derived: sum of 2 quarters · filed 2026-08-13
$4.76M
10-Q · filed 2025-11-13
$4.86M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$1.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$2.56M
10-Q · filed 2026-08-13
$2.66M
derived: sum of 3 quarters · filed 2026-08-13
$3.15M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$1.20M
10-Q · filed 2026-05-13
$1.29M
derived: sum of 2 quarters · filed 2026-05-13
$1.79M
derived: sum of 3 quarters · filed 2026-05-13
$1.84M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$98.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$593.00K
derived: sum of 2 quarters · filed 2026-02-26
$644.00K
derived: sum of 3 quarters · filed 2026-02-26
$730.00K
10-K · filed 2026-02-26
2024-09-30$495.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$546.00K
derived: sum of 2 quarters · filed 2025-11-13
$632.00K
10-Q · filed 2025-11-13
$813.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$51.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$137.00K
10-Q · filed 2025-08-12
$318.00K
derived: sum of 3 quarters · filed 2025-08-12
$883.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$86.00K
10-Q · filed 2025-05-13
$267.00K
derived: sum of 2 quarters · filed 2025-05-13
$832.00K
derived: sum of 3 quarters · filed 2025-05-13
$3.03M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$181.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$746.00K
derived: sum of 2 quarters · filed 2025-03-05
$2.94M
derived: sum of 3 quarters · filed 2025-03-05
$6.15M
10-K · filed 2025-03-05
2023-09-30$565.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$2.76M
derived: sum of 2 quarters · filed 2024-11-12
$5.97M
10-Q · filed 2024-11-12
$12.65M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$2.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$5.41M
10-Q · filed 2024-08-13
$12.08M
derived: sum of 3 quarters · filed 2024-08-13
$20.76M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$3.21M
10-Q · filed 2024-05-09
$9.88M
derived: sum of 2 quarters · filed 2024-05-09
$18.56M
derived: sum of 3 quarters · filed 2024-05-09
$28.69M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$6.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$15.35M
derived: sum of 2 quarters · filed 2024-02-26
$25.48M
derived: sum of 3 quarters · filed 2024-02-26
$35.57M
10-K · filed 2024-02-26
2022-09-30$8.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$18.80M
derived: sum of 2 quarters · filed 2023-11-08
$28.89M
10-Q · filed 2023-11-08
$47.26M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$10.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$20.21M
10-Q · filed 2023-08-08
$38.58M
derived: sum of 3 quarters · filed 2023-08-08
$53.32M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$10.08M
10-Q · filed 2023-05-03
$28.45M
derived: sum of 2 quarters · filed 2023-05-03
$43.19M
derived: sum of 3 quarters · filed 2023-05-03
$56.81M
derived: sum of 4 quarters · filed 2023-05-03
2021-12-31$18.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$33.10M
derived: sum of 2 quarters · filed 2023-02-28
$46.72M
derived: sum of 3 quarters · filed 2023-02-28
$50.70M
10-K · filed 2023-02-28
2021-09-30$14.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$28.35M
derived: sum of 2 quarters · filed 2022-11-03
$32.34M
10-Q · filed 2022-11-03
$34.61M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$13.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$17.60M
10-Q · filed 2022-08-03
$19.87M
derived: sum of 3 quarters · filed 2023-02-28
$20.83M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$3.98M
10-Q · filed 2022-05-04
$6.25M
derived: sum of 2 quarters · filed 2023-02-28
$7.21M
derived: sum of 3 quarters · filed 2023-02-28
$7.84M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$2.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$3.23M
derived: sum of 2 quarters · filed 2023-02-28
$3.86M
derived: sum of 3 quarters · filed 2023-02-28
$4.93M
10-K · filed 2023-02-28
2020-09-30$954.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.59M
derived: sum of 2 quarters · filed 2021-11-04
$2.66M
10-Q · filed 2021-11-04
$5.25M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$636.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$1.71M
10-Q · filed 2021-08-04
$4.30M
derived: sum of 3 quarters · filed 2022-02-28
$5.56M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$1.07M
10-Q · filed 2021-05-05
$3.66M
derived: sum of 2 quarters · filed 2022-02-28
$4.92M
derived: sum of 3 quarters · filed 2022-02-28
$6.72M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$2.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$3.85M
derived: sum of 2 quarters · filed 2022-02-28
$5.65M
derived: sum of 3 quarters · filed 2022-02-28
$7.39M
10-K · filed 2022-02-28
2019-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$3.06M
derived: sum of 2 quarters · filed 2020-11-05
$4.80M
10-Q · filed 2020-11-05
$5.92M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$1.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$3.54M
10-Q · filed 2020-08-05
$4.66M
derived: sum of 3 quarters · filed 2021-02-24
$5.38M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$1.75M
10-Q · filed 2020-05-11
$2.86M
derived: sum of 2 quarters · filed 2021-02-24
$3.59M
derived: sum of 3 quarters · filed 2021-02-24
$3.87M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$1.84M
derived: sum of 2 quarters · filed 2021-02-24
$2.12M
derived: sum of 3 quarters · filed 2021-02-24
$2.30M
10-K · filed 2021-02-24
2018-09-30$724.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$1.00M
derived: sum of 2 quarters · filed 2019-11-05
$1.19M
10-Q · filed 2019-11-05
$1.98M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$278.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$462.00K
10-Q · filed 2019-08-06
$1.26M
derived: sum of 3 quarters · filed 2020-03-02
$1.62M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$184.00K
10-Q · filed 2019-05-07
$981.00K
derived: sum of 2 quarters · filed 2020-03-02
$1.34M
derived: sum of 3 quarters · filed 2020-03-02
$1.75M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$797.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$1.16M
derived: sum of 2 quarters · filed 2020-03-02
$1.57M
derived: sum of 3 quarters · filed 2020-03-02
$1.73M
10-K · filed 2020-03-02
2017-09-30$362.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$773.00K
derived: sum of 2 quarters · filed 2018-11-01
$928.00K
10-Q · filed 2018-11-01
$968.00K
derived: sum of 4 quarters · filed 2019-03-05
2017-06-30$411.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
$566.00K
10-Q · filed 2018-08-06
$606.00K
derived: sum of 3 quarters · filed 2019-03-05
$639.00K
derived: sum of 4 quarters · filed 2019-03-05
2017-03-31$155.00K
10-Q · filed 2018-05-10
$195.00K
derived: sum of 2 quarters · filed 2019-03-05
$228.00K
derived: sum of 3 quarters · filed 2019-03-05
$434.00K
derived: sum of 4 quarters · filed 2019-03-05
2016-12-31$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05
$73.00K
derived: sum of 2 quarters · filed 2019-03-05
$279.00K
derived: sum of 3 quarters · filed 2019-03-05
$457.00K
10-K · filed 2019-03-05
2016-09-30$33.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$239.00K
derived: sum of 2 quarters · filed 2017-11-01
$417.00K
10-Q · filed 2017-11-01
$595.00K
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30$206.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$384.00K
10-Q · filed 2017-08-14
$562.00K
derived: sum of 3 quarters · filed 2018-03-05
$1.22M
derived: sum of 4 quarters · filed 2018-03-05
2016-03-31$178.00K
10-Q · filed 2017-05-15
$356.00K
derived: sum of 2 quarters · filed 2018-03-05
$1.01M
derived: sum of 3 quarters · filed 2018-03-05
$1.22M
derived: sum of 4 quarters · filed 2018-03-05
2015-12-31$178.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$833.00K
derived: sum of 2 quarters · filed 2018-03-05
$1.05M
derived: sum of 3 quarters · filed 2018-03-05
$1.50M
10-K · filed 2018-03-05
2015-09-30$655.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$868.00K
derived: sum of 2 quarters · filed 2016-11-07
$1.32M
10-Q · filed 2016-11-07
$1.59M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$213.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$665.00K
10-Q · filed 2016-08-08
$936.00K
derived: sum of 3 quarters · filed 2017-03-16
$1.12M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$452.00K
10-Q · filed 2016-05-09
$723.00K
derived: sum of 2 quarters · filed 2017-03-16
$910.00K
derived: sum of 3 quarters · filed 2017-03-16
$936.00K
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$271.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$458.00K
derived: sum of 2 quarters · filed 2017-03-16
$484.00K
derived: sum of 3 quarters · filed 2017-03-16
$882.00K
10-K · filed 2017-03-16
2014-09-30$187.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03
$213.00K
derived: sum of 2 quarters · filed 2015-11-03
$611.00K
10-Q · filed 2015-11-03
$761.00K
derived: sum of 4 quarters · filed 2016-03-03
2014-06-30$26.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$424.00K
10-Q · filed 2015-08-05
$574.00K
derived: sum of 3 quarters · filed 2016-03-03
$597.00K
derived: sum of 4 quarters · filed 2016-03-03
2014-03-31$398.00K
10-Q · filed 2015-05-07
$548.00K
derived: sum of 2 quarters · filed 2016-03-03
$571.00K
derived: sum of 3 quarters · filed 2016-03-03
$635.00K
derived: sum of 4 quarters · filed 2016-03-03
$4.06M
10-Q · filed 2014-05-13
2013-12-31$150.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03
$173.00K
derived: sum of 2 quarters · filed 2016-03-03
$237.00K
derived: sum of 3 quarters · filed 2016-03-03
$244.00K
10-K · filed 2016-03-03
$3.66M
10-K · filed 2014-03-17
2013-09-30$23.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$87.00K
derived: sum of 2 quarters · filed 2014-11-12
$94.00K
10-Q · filed 2014-11-12
$389.00K
derived: sum of 4 quarters · filed 2015-03-12
$3.51M
10-Q · filed 2013-11-13
2013-06-30$64.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$71.00K
10-Q · filed 2014-08-12
$366.00K
derived: sum of 3 quarters · filed 2015-03-12
2013-03-31$7.00K
10-Q · filed 2014-05-13
$302.00K
derived: sum of 2 quarters · filed 2015-03-12
2012-12-31$295.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$709.00K
10-K · filed 2015-03-12
2012-09-30$414.00K
10-Q · filed 2013-11-13
2011-12-31$2.00K
10-K · filed 2014-03-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35